HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Down-regulation of mitochondrial gene expression by the anti-tumor arotinoid mofarotene (Ro 40-8757).

Abstract
To understand the mechanism of action of the antitumor arotinoid mofarotene (Ro 40-8757), differential screening of cDNA libraries with cDNA probes prepared from treated or untreated breast-cancer cells was performed. Several genes were identified that appeared to be regulated by mofarotene, including a mitochondrial gene encoding a subunit of NADH dehydrogenase (NDI). This gene was down-regulated in the breast-cancer cell line MDA-MB-231 after treatment with the arotinoid for 3 to 6 hr. Down-regulation of NDI was detected in 2 other breast-carcinoma cell lines (ZR-75-I and MCF-7) and a pancreatic cancer cell line (BxPC3), but not in the normal fibroblast cell line Wi-38 or several other tumor cell lines. This effect was blocked by addition of cycloheximide to the medium. The retinoids, all-trans and 9-cis retinoic acids, did not affect the expression of NDI in MDA-MB-231 cells, demonstrating that mofarotene was not acting through the nuclear retinoic-acid receptors. In the estrogen-receptor-expressing breast-cancer line ZR-75-I, tamoxifen had no effect on NDI expression. The cytotoxic drugs doxorubicin, 5-FU and vincristine also had no effect on regulation of this gene. Two mitochondrial proteins encoded in the nucleus, ATPase beta subunit and mitochondrial transcription factor I, were not down-regulated by mofarotene. Addition of mofarotene to cells incubated in glucose-free medium led to their death. These results indicate that down-regulation of mitochondrial gene transcription is specific to mofarotene and may explain, in part, the anti-proliferative effects of this compound.
AuthorsT Uchida, N Inagaki, Y Furuichi, J F Eliason
JournalInternational journal of cancer (Int J Cancer) Vol. 58 Issue 6 Pg. 891-7 (Sep 15 1994) ISSN: 0020-7136 [Print] United States
PMID7927884 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • DNA Probes
  • DNA, Mitochondrial
  • DNA, Neoplasm
  • Morpholines
  • Retinoids
  • mofarotene
  • NADH Dehydrogenase
Topics
  • Antineoplastic Agents (pharmacology)
  • Base Sequence
  • Blotting, Northern
  • Cell Division (drug effects, physiology)
  • DNA Probes
  • DNA, Mitochondrial (genetics)
  • DNA, Neoplasm (genetics)
  • Down-Regulation (drug effects)
  • Gene Expression (drug effects)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Genome, Human
  • Humans
  • Kinetics
  • Mitochondria (drug effects, physiology)
  • Molecular Sequence Data
  • Morpholines (pharmacology)
  • NADH Dehydrogenase (genetics)
  • Neoplasms (genetics)
  • Retinoids (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: